Caroline Denevault-Sabourin

6PUBLICATIONS
25CO-AUTHORS
Metal cluster chemistryCancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesMolecular targetsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 01, 2026
Modular CuAAC-Based Synthesis of C-Functional Cyclam-Picolinate Chelators for Antibody Conjugation.

Cédric Ollier, Dyhia Amrane, Guillaume Gabant

|Sep 05, 2025
Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer.

Etienne Auvert, Emmanuel Douez, Louis Jolivet

|Jan 08, 2023
Synthesis and In Vitro Comparison of DOTA, NODAGA and 15-5 Macrocycles as Chelators for the 64Cu-Labelling of Immunoconjugates.

Aurélie Maisonial-Besset, Tiffany Witkowski, Mercedes Quintana

|Jul 27, 2022
Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment-Drug Conjugates (FDCs).

Louis Jolivet, Imène Ait Mohamed Amar, Catherine Horiot

|Nov 13, 2021
Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases.

Viet Hung Dao, Isabelle Ourliac-Garnier, Cédric Logé

|Jul 02, 2021
Internalization of Foldamer-Based DNA Mimics through a Site-Specific Antibody Conjugate to Target HER2-Positive Cancer Cells.

Valentina Corvaglia, Imène Ait Mohamed Amar, Véronique Garambois

Pageof 1